LENZ Therapeutics LENZ
NASDAQ LENZ
$4.11 +0.01 (+0.24%)
At close: Nov 11, 2026 · 4:00 PM EST

LENZ Therapeutics (LENZ) Liabilities and Shareholders Equity (2020 - 2026)

Updated

Analysis

LENZ Therapeutics (LENZ) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 LENZ Therapeutics 128.82 Mn -839.21 Mn 2.93 Mn 209.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 209.75 Mn
Jun 30, 2026 236.60 Mn
Mar 31, 2026 272.54 Mn
Dec 31, 2025 305.88 Mn
Sep 30, 2025 210.70 Mn
Jun 30, 2025 217.33 Mn
Mar 31, 2025 201.25 Mn
Dec 31, 2024 215.30 Mn
Sep 30, 2024 224.01 Mn
Jun 30, 2024 202.64 Mn
Mar 31, 2024 217.32 Mn
Dec 31, 2023 70.38 Mn
Sep 30, 2023 266.23 Mn
Jun 30, 2023 287.04 Mn
Mar 31, 2023 310.00 Mn
Dec 31, 2022 321.90 Mn
Sep 30, 2022 334.85 Mn
Jun 30, 2022 353.79 Mn
Mar 31, 2022 378.61 Mn
Dec 31, 2021 401.99 Mn
API Access

LENZ Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=LENZ&period=max&api_key=YOUR_API_KEY